Poolbeg Pharma shares up after US FDA orphan drug designation
27th May 2025 12:19
(Alliance News) - Poolbeg Pharma PLC on Tuesday announced that it received an orphan drug designation from the US Food & Drug Administration. Read More
| Price | 3.60p on 28-05-2025 at 18:35:10 |
|---|---|
| Change | -0.10p -2.6% |
| Buy | 3.70p |
| Sell | 3.50p |
| Buy / Sell POLB Shares | |
| Last Trade: | Buy 63,924.00 at 3.75p |
| Day's Volume: | 13,421,763 |
| Last Close: | 3.75p |
| Open: | 3.85p |
| ISIN: | GB00BKPG7Z60 |
| Day's Range | 3.75p - 4.00p |
| 52wk Range: | 2.40p - 14.30p |
| Market Capitalisation: | £26m |
| VWAP: | 3.792674p |
| Shares in Issue: | 697m |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Poolbeg Pharma (POLB) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 63,924 | 3.75p | Suspected BUY Trade |
16:35:23 - 28-May-25 |
| Sell* | 1 | 3.58p | Ordinary |
16:29:27 - 28-May-25 |
| Sell* | 1 | 3.58p | Ordinary |
16:28:44 - 28-May-25 |
| Buy* | 1,000 | 3.70p | Ordinary |
16:28:33 - 28-May-25 |
| Buy* | 1,000 | 3.70p | Ordinary |
16:28:07 - 28-May-25 |
| Sell* | 1 | 3.58p | Ordinary |
16:26:10 - 28-May-25 |
| Sell* | 1 | 3.58p | Ordinary |
16:25:13 - 28-May-25 |
| Sell* | 1 | 3.58p | Ordinary |
16:20:28 - 28-May-25 |
| Sell* | 33,133 | 3.58p | Ordinary |
16:20:19 - 28-May-25 |
| Sell* | 1 | 3.58p | Ordinary |
16:19:50 - 28-May-25 |
Poolbeg Pharma (POLB) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 27th May 2025 7:01 am | RNS | FDA Orphan Drug Designation granted for POLB 001 |
| 27th May 2025 7:00 am | RNS | Annual Report, AGM Notice & Circular |
| 23rd May 2025 7:00 am | RNS | Result of upsized oversubscribed BookBuild Offer |
| 22nd May 2025 1:44 pm | RNS | Increase of BookBuild Offer |
| 20th May 2025 12:26 pm | RNS | Result of Placing and Notice of General Meeting |
| 20th May 2025 7:02 am | RNS | Proposed Retail Offer to raise up to £100,000 |
| 20th May 2025 7:01 am | RNS | Proposed Fundraising to raise approximately £4.1M |
| 20th May 2025 7:00 am | RNS | Results for the year ended 31 December 2024 |
| 27th Mar 2025 7:00 am | RNS-R | Conference Participation in March & April 2025 |
| 20th Mar 2025 7:00 am | RNS-R | POLB 001 Patent Granted in Korea |